Literature DB >> 1739928

Familial occurrence of infantile myofibromatosis.

M Bracko1, L Cindro, R Golouh.   

Abstract

Two brothers with multicentric infantile myofibromatosis (IM) are reported. In both, tumors were present at birth; the tumors regressed spontaneously, but new lesions developed throughout the follow-up periods of 15 and 8 years. Immunohistochemically, the nodules were found to be positive for vimentin and actin, but negative for desmin and S-100 protein; these findings support the myofibroblastic nature of IM. A literature review revealed nine additional families with IM in more than one family member. Although the occurrence of IM in eight sets of siblings, with consanguinity in two of them, favors an autosomal recessive mode of inheritance, the disorder also has been well documented in half-sisters and in successive generations, which makes autosomal dominant inheritance a more plausible explanation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739928     DOI: 10.1002/cncr.2820690537

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Non-malignant fibrosing tumors in the pediatric hand: a clinicopathologic case review.

Authors:  David T Netscher; Michael A Baumholtz; Edwina Popek; Adam M Schneider
Journal:  Hand (N Y)       Date:  2008-12-02

2.  Infantile myofibromatosis.

Authors:  J F Chateil; M Brun; B Lebail; Y Perel; J F Castell; F Diard
Journal:  Skeletal Radiol       Date:  1995-11       Impact factor: 2.199

3.  PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.

Authors:  F A Arts; D Chand; C Pecquet; A I Velghe; S Constantinescu; B Hallberg; J-B Demoulin
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

4.  Endocardial location of familial myofibromatosis revealed by cerebral embolization: cardiac counterpart of the frequent intravascular growth of the disease?

Authors:  Vincent Thomas de Montpréville; Leila Zemoura; Guy Vaksmann; Godeleine Lecourt-Tierny; Claude Planché; Elisabeth Dulmet
Journal:  Virchows Arch       Date:  2004-01-09       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.